The Effect of Harm Reductions Program on the Injection Behavior of Injection Drug Users in Indonesia by Ocnisari, Istiqomah Nur & ., Besral
ICGH Conference Proceedings
The 1st International Conference on Global Health
Volume 2017
Conference Paper
The Effect of Harm Reductions Program on
the Injection Behavior of Injection Drug Users
in Indonesia
Istiqomah Nur Ocnisari and Besral
Department of Biostatistic and Population Studies, Faculty of Public Health, Universitas
Indonesia, Depok, Indonesia
Abstract
This study aimed to identify the effect of HIV-AIDS harm reduction program on the
injection behavior of injection drug users (IDUs). This study used a cross-sectional
survey secondary data from the Indonesia Integrated Biological and Behavioral Survey
of 2013, selecting 430 IDU respondents who had met with outreach workers in 4 major
cities, namely Yogyakarta, Tangerang, Pontianak, and Makassar. Multiple logistic
regressions were performed to determine the effect of harm reduction program.
The proportion of IDUs who had engaged in risky behavior was 44.3%, and that of
IDUs who had not accessed harm reduction programs was 54.1%. The effect of harm
reduction programs on the risky injection behavior of these IDUs varied according
to marital status. Among unmarried IDUs, those who did not access harm reduction
programs had a 1.3 times higher chance of engaging in risky injection (ORa 1.3, 95%
CI 0.6-2.7). Among married IDUs, those who did not access harm reduction programs
had a 5.4 times higher chance of engaging in risky injection (ORa 5.4, 95% CI 3.6-8.1).
Other factors contributing to injection behavior were age, living area, condom use, the
duration of injection drugs use, and the total number of injection partners. More effort
is required to optimalize harm reduction programs and make them comprehensive in
order to decrease risky injection behaviors and thereby prevent HIV-AIDS transmission
among IDUs.
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1. INTRODUCTION
Formore than 3 decades, theworld has faced an epidemic of Human Immunodeficiency
Virus (HIV), and to this day, a cure for those infected with HIV has not been found.
Injection drug abuse is one of the main forces driving the spread of HIV. One in 10
of new HIV infections around the world is caused by contaminated syringes use by
injection drug users. Drugs injection has been a global problems and it is estimated
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that there are about 15.9 million injection drug users (IDU) worldwide, of which about
3million are HIV-positive [8]. In some countries, the incidence of HIV infection in the IDU
population has increased by 40%. In 2013, a global report showed a high prevalence of
HIV in the IDU population (UNAIDS 2013). Since 2000, the prevalence of HIV in Indonesia
has increased to over 5% in key populations. According to the Indonesia Integrated
Biological and Behavioral Survey (IBBS) of 2013, IDU are the key population with the
highest HIV prevalence, i.e. by 39.2%, followed by men who engage in homosexual
intercorse (12.8%), transgender (7.4%), and female sex workers (1.6%).
The IDU population has a doubled risk of HIV transmission, namely through the use
of hypodermic needles and through sexual transmission. The use of shared needles
is a common practice among IDUs. Studies in several countries have that those who
angege in group use of injection drugs are very vulnerable to contracting HIV through
the interchange of drugs injection without adequate sterilization. Almost half of IDUs
have at some point shared drugs in a group and used the share needles [14].
Intervention programs for the prevention of HIV transmission among IDUs are car-
ried out through injection drugs harm reduction program. Harm reduction program
is defined as an approach to the individual or group that aims to reduce the risks
related to a behavior. Almost all member states of the United Nations support harm
reduction programs for drug injection. Until the year 2010, sterile syringe services
had been applied in 70 countries, and opioid substitution therapy programs had been
implemented in 82 countries, of which 66 countries implemented both interventions
[8]. Rapid and appropriate response is urgently needed in Indonesia. This study aimed
to determine the effect of an HIV-AIDS harm reduction program of HIV-AIDS on the
injection behavior of IDUs in Indonesia.
2. METHODS
The data used in this studywere secondary data on IDUs from Integrated Biological and
Behavioral Survey from the year 2013. These data were collected by the Ministry of
Health in 4 major cities in Indonesia, namely Yogyakarta, Tangerang, Pontianak, and
Makassar. The study’s design was cross-sectional. The population considered in this
study was made up of all IDUs who netted the sample in the four cities. The 430 IDUs
who were included in the sample were selected based on the criterion that they had
met with outreach or field workers whowerewith HIV-AIDS prevention programs. IDUs
were considered to exhibit no risky injection behavior if the had never shared needles,
never used public syringes, and never shared drugs after mixing them with water.
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T 1: Risky Injection Behavior and Access to Harm Reduction Programs of Injection Drug Users (n=430)
Injection Behavior and Harm Reduction n %
Risky Injection Behavior 190 44.3
Share needles 88 20.5
Use public syringes 52 12.1
Share drugs 150 34.9
Good Access to Harm Reduction Programs 197 45.9
Sterile syringe services 290 67.4
Opioid Substitution therapy 30 6.8
Counseling and testing for HIV 334 77.6
Sexually transmitted infections services 103 23.9
Promotion of condom 242 56.3
Communication, Information, & Education 389 90.5
Antiretroviral therapy 146 33.9
Hepatitis services 62 14.4
Tuberculosis services 81 18.9
Access to harm reduction programs was measured through 9 questions, which were
then composited with the Principal Component Analysis method. Those who score
above the median value were considered to have good access to services. Analysis of
the data to determine the effects of harm reduction programs on injection behavior
was performed by multivariate logistic regression.
3. RESULTS
Most IDUs were men (93%) older than 24 years (83%), who had graduated from high
school or higher education (80.9%), were unmarried (53.8%), had no fixed income (69,
9%), poor knowledge about HIV-AIDS prevention (56%), and poor knowledge about
HIV-AIDS transmission (54%). The drugs types most commonly injected by IDUs was
opioids (92.7%). Most IDUs had been injecting for over 4 years (75.3%), were injecting
more than 3 times per month (60.1%), were injecting along with more than 2 other
people (74.9%) and had never gone to jail (59.8%).
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T 2: Final Logistic Regression Model of Risky Behavior among IDUs
Independent Variable of IDUs B *ORa 95% CI ORa Sig.
No access to harm reduction programs 0.248 1.3 0.6–2.7 0.237
Aged less than 25 years 1.241 3.5 1.4–8.8 0.011
Unmarried 0.421 1.5 0.7–3.3 0.358
Opioid consumed 0.633 1.9 0.7–5.2 0.221
Injecting drugs for more than 4 years 0.865 2.4 1.0–5.5 0.044
Injecting with more than 2 other persons 1.677 5.3 2.8–10.2 0.001
No access to harm reduction programs *
Unmarried
1.442 0.024
No access to harm reduction programs among
those unmarried
1.3 0.6–2.7
No access to harm reduction programs among
those married
5.4 3.6–8.1
*ORa = Adjusted Odds Ratio
Table 1 shows that of 430 respondents, 44% engaged in risky injection behavior.
IDUs who accessed harm reduction programs made up only 46%. Of the 9 compo-
nents of harm reduction programs, the components to which access was still low were
opioid substitution therapy (6.8%), sexually transmitted infections services (23.9%),
antiretroviral therapy (33.9%), hepatitis services (14.4%), and tuberculosis services
(18.9%).
Based on Table 2, the results ofmultivariable analysis showed that the effect of harm
reduction programs on injection behavior differed according to marital status. Among
unmarried IDUs, those who did not have good access to harm reduction programs
exhibited 1.3 times more risky injection behaviors than those who were accessing the
programs. Meanwhile, among married IDUs, those who did not have good access to
harm reduction programs exhibited 1.3 times more risky injection behaviors than those
who were accessing the programs. Other factors that increased the likelihood of risky
injection behaviors were being younger than 25 (ORa 3.5), using opioids (ORa 1.9),
having been IDUs for more than 4 years (ORa 2.4) and having injected together with
more than 2 other persons (ORa 5.3).
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4. DISCUSSION
Behavior theory mention that the access to a harm reduction programs is one of
the enabling factors that influence an individual’s or a group’s behavior. According to
the Asian Harm Reduction Network and the Centre for Harm Reduction, Burnet Insti-
tute (2003), IDUs who access harm reduction programs will reduce their risk syringes-
sharing so as to reduce the spread of HIV-AIDS epidemic.
The results of this study shows that IDUs who were not accessing harm reduction
programs tended to inject at risk. Sterile syringe services are one component of the
harm reduction programs. Sartika (2013) showed that IDUs who did not access sterile
syringe services had a 1.9 times higher chance risky injection behavior than those
who did access these services. A study conducted by Lausevic (2015) showed a 5.7
times higher likelihood of risky injection behavior in those who did not have good
access to harm reduction programs. These results were obtained after controlling for
age, gender, income, frequency of injection, number of sex partners, and area of
injection. Other study conducted by Bluthenthal (2000), Perngmark (2003), and Kral
(2004) showed the same results, i.e., lack of access to harm reduction programs led to
a greater likelihood of risky injection behaviors.
In addition to sterile injection equipment services, substitution therapy programs
using methadone and buprenorphine are also components of harm reduction pro-
grams. In this study, of the 9 components of a harm reduction program, the one to
which the least access was available was therapy programs; their level of accessibility
amounted to 6.8%. Methadone and buprenorphine are believed to encourage IDUs to
reduce the frequency of injection drug use, thus reducing the chance of their shar-
ing injection equipment. This was proven by Gowing (2005), whose research showed
that there was a significant correlation between access to methadone therapy and a
decrease in the frequency of injection drug use.
According to Wodak (2010), opioid substitution therapy and providing sterile
syringes widely could halt the HIV-AIDS epidemic and lead to a decline in HIV preva-
lence among IDUs. Thus, the government and private organizations are expected to
make an effort to promote a harm reduction programs by expanding each component
of such programs, including sterile injection equipment services and maintenance
therapy with methadone and buprenorphine.
Other factors contributing to risky injection behavior were age, marital status, the
type of drug use, the length of time since the user’ had become an IDUs, and the
user’s number of injection partner. These results are in line with Mandell’s (1994) and
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Valente’s (2001) results, which showed that younger IDUs had a 1.4 times higher risk
of engaging risky injection behavior than older IDUs. Mawarni’s study (2008) showed
similar results – that youth were 1.9 times more at risk of risky injection behavior
compared to older IDUs.
In theory, the long-term use of injection drugs was one of the factors reinforcing
IDUs’ injection behavior. The results showed that IDUs who had been injecting for more
than 4 years had a 2.5 times higher risk of risky injection compared to IDUs who had
injected for less than 4 years. Iryawan study (2013) showed that IDUs who are new to
or seldom use injection drugs tend to gather with peers who have the same behavioral
patterns. Likewise, IDUs who have long used drugs will gather with peers who have
similar characteristics.
5. CONCLUSIONS
The proportion of IDUs who engaged in risky injection behavior was 44.3% and IDUs
who did not access harm reduction programs was 54.1%. The effect of harm reduction
programs on the risky injection behavior of IDUs varied according to marital status.
Among unmarried IDUs, those who did not access harm reduction programs had a 1.3
times higher likelihood of engaging in risky injection behavior (ORa 1.3, 95% CI 0.6
- 2.7). Among married IDUs, those who did not access harm reduction programs had
a 5.4 times higher chance of engaging in risky injection behavior (ORa 5.4, 95% CI
3.6—8.1). Other factors contributing to injection behavior were age, area of injection,
condom use, the duration of injection drugs use, and the total number of injection
partner. More efforts are required to optimize harm reduction programs and make
them comprehensive in order to decrease risky injection behavior and prevent HIV-
AIDS transmission.
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